India drug discovery informatics market was valued at $69.7 million in 2025 and is projected to reach $207.7 million by 2035, growing at a CAGR of 11.6% during the forecast period (2026–2035). Drug discovery informatics in India involves the use of computational modeling, virtual screening, molecular docking, structure-based drug design, sequencing and target data analysis, and database management to streamline and accelerate drug development processes. The market is witnessing rapid growth in India, driven by the expansion of pharmaceutical and biotechnology research, increasing outsourcing of R&D to contract research organizations (CROs), and rising adoption of AI- and cloud-based informatics platforms. Government initiatives promoting innovation, digitalization, and life sciences research, along with the growing focus on precision medicine and cost-effective drug development, are further supporting market expansion.
Browse the full report description of “Indian Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/indian-drug-discovery-informatics-market
According to GenomeIndia, India is rapidly advancing its capabilities in drug discovery informatics through large-scale national genomic sequencing projects, publicly accessible bioinformatics resources, and high-performance computational platforms. These initiatives are enabling pharmaceutical, biotechnology, and academic organizations to accelerate molecular modeling, docking, sequencing and target analysis, and database preparation workflows. The integration of national genomic datasets with open protein and chemical databases is strengthening India’s position in data-driven drug discovery.
Key Innovators Driving India Drug Discovery Informatics Transformation
The key players in the India drug discovery informatics market include Accenture plc, Infosys Limited, PerkinElmer, Inc, Syngene International Limited, Thermo Fisher Scientific Inc., among others. These companies are advancing innovation through AI-powered modeling platforms, integrated informatics solutions, and high-throughput computational tools, playing a pivotal role in transforming drug discovery and R&D workflows in India.
Market Coverage
Key questions addressed by the report.
India Drug Discovery Informatics Market Report Segment
By Function
By End-Users
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/indian-drug-discovery-informatics-market